Literature DB >> 30796009

Striatal dopamine activity and myocardial 123I-metaiodobenzylguanidine uptake in early Parkinson's disease.

Yoon-Sang Oh1, Joong-Seok Kim2, Sang-Won Yoo1, Eo-Jin Hwang3, Chul Hyoung Lyoo4, Kwang-Soo Lee1.   

Abstract

INTRODUCTION: Dopamine transporter imaging and myocardial 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy have been widely used to diagnose and discriminate degenerative parkinsonism. Many studies have reported that both imaging findings are associated with a variety of motor and non-motor phenomena in Parkinson's disease (PD). However, the association between striatal dopamine activity and myocardial 123I-MIBG uptake has not been well investigated. The objective of this study is to identify the dopamine transporter activity of the corpus striatum and thalamus according to myocardial 123I-MIBG uptake in PD.
METHODS: Ninety-six newly diagnosed, non-medicated PD patients were enrolled. All patients underwent 123I-MIBG myocardial scintigraphy, positron emission tomography (PET) using 18FN-(3-fluoropropyl)-2beta-carbon ethoxy-3beta-(4-iodophenyl) nortropane and T1-weighted magnetic resonance imaging (MRI). Patients were stratified into normal and decreased 123I-MIBG groups according to their delayed heart-to-mediastinum ratio (cutoff value = 1.78). After normalizing the PET images with spatially normalized MRI, the regional standardized uptake value ratios (SUVRs) were analyzed with a volume-of-interest template between the two groups.
RESULTS: Thirty-one patients showed normal myocardial 123I-MIBG uptake, and 65 patients showed reduced uptake. The SUVR of the globus pallidus in the group with reduced 123I-MIBG uptake was significantly lower than the SUVR in the normal 123I-MIBG uptake group. The heart-to-mediastinum ratio was correlated well with the SUVR of the globus pallidus, independent of age, disease duration, and the severity of motor symptoms.
CONCLUSION: Early PD patients with normal 123I-MIBG uptake showed a relatively preserved dopamine reserve in the globus pallidus than patients with reduced 123I-MIBG uptake.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (123)I-metaiodobenzylguanidine scintigraphy; Dopamine transporter scan; Parkinson's disease

Mesh:

Substances:

Year:  2019        PMID: 30796009     DOI: 10.1016/j.parkreldis.2019.02.012

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  2 in total

1.  Intrasubject relationship between striatal 18F-FP-CIT uptake and cardiac 123I-MIBG uptake differs by motor subtype in early Parkinson disease.

Authors:  Wooyoung Jang; Ji Young Lee; Ji Young Kim; Soo Jin Lee; Tae Yoon Kim; Yun Young Choi; Hee-Tae Kim; Chun K Kim
Journal:  Medicine (Baltimore)       Date:  2021-08-20       Impact factor: 1.817

Review 2.  Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review.

Authors:  Shuangqiu Wang; Jiarui Ma; Yanqi Zeng; Guowei Zhou; Yuxuan Wang; Wenjuan Zhou; Xiaohe Sun; Minghua Wu
Journal:  Drug Des Devel Ther       Date:  2021-08-20       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.